These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8448727)

  • 1. The use of antidepressants in the treatment of children with behaviour disorders.
    Huessy HR
    Can J Psychiatry; 1993 Feb; 38(1):68-9. PubMed ID: 8448727
    [No Abstract]   [Full Text] [Related]  

  • 2. Which boys respond to stimulant medication? A controlled trial of methylphenidate in boys with disruptive behaviour.
    Taylor E; Schachar R; Thorley G; Wieselberg HM; Everitt B; Rutter M
    Psychol Med; 1987 Feb; 17(1):121-43. PubMed ID: 3554290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drugs in management of minimal brain dysfunction.
    Millichap JG
    Ann N Y Acad Sci; 1973 Feb; 205():321-34. PubMed ID: 4144050
    [No Abstract]   [Full Text] [Related]  

  • 4. Attention deficit disorder with and without hyperactivity: clinical response to three dose levels of methylphenidate.
    Barkley RA; DuPaul GJ; McMurray MB
    Pediatrics; 1991 Apr; 87(4):519-31. PubMed ID: 2011430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The concurrent use of lithium and methylphenidate in a child.
    Licamele WL; Goldberg RL
    J Am Acad Child Adolesc Psychiatry; 1989 Sep; 28(5):785-7. PubMed ID: 2507515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug therapy in minimal brain dysfunction: a commentary.
    Erenberg G
    J Pediatr; 1972 Aug; 81(2):359-65. PubMed ID: 4557602
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of methylphenidate on attention-deficit hyperactivity disorder with and without aggressive/noncompliant features.
    Klorman R; Brumaghim JT; Salzman LF; Strauss J; Borgstedt AD; McBride MC; Loeb S
    J Abnorm Psychol; 1988 Nov; 97(4):413-422. PubMed ID: 3060506
    [No Abstract]   [Full Text] [Related]  

  • 8. A pilot study: differential effects of methylphenidate-OROS on working memory and attention functions in children with attention-deficit/hyperactivity disorder with and without behavioural comorbidities.
    Rubio B; Hernández S; Verche E; Martín R; González-Pérez P
    Atten Defic Hyperact Disord; 2011 Mar; 3(1):13-20. PubMed ID: 21432614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reboxetine use in the treatment of attention-deficit/hyperactivity disorder.
    Cak HT; Cetin FC
    J Child Adolesc Psychopharmacol; 2006 Dec; 16(6):803-4. PubMed ID: 17201625
    [No Abstract]   [Full Text] [Related]  

  • 10. Buspirone for aggression.
    Quiason N; Ward D; Kitchen T
    J Am Acad Child Adolesc Psychiatry; 1991 Nov; 30(6):1026. PubMed ID: 1757432
    [No Abstract]   [Full Text] [Related]  

  • 11. Using psychoactive medication to intervene in children's behaviour: an evidence-based practice?
    Parsonson BS
    J Prim Health Care; 2009 Mar; 1(1):6-10. PubMed ID: 20690480
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral medications for minimal brain dysfunction in children.
    Green RP; Scales SM; Rosser PL
    J Natl Med Assoc; 1973 Mar; 65(2):157-60. PubMed ID: 4691677
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of methylphenidate and expectancy on children with ADHD: behavior, academic performance, and attributions in a summer treatment program and regular classroom settings.
    Pelham WE; Hoza B; Pillow DR; Gnagy EM; Kipp HL; Greiner AR; Waschbusch DA; Trane ST; Greenhouse J; Wolfson L; Fitzpatrick E
    J Consult Clin Psychol; 2002 Apr; 70(2):320-35. PubMed ID: 11952190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy of methylphenidate in children and adolescents.
    Klein RG
    Encephale; 1993; 19(2):89-93. PubMed ID: 8275902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic treatment of psychiatric and neurodevelopmental disorders in children and adolescents (Part 1).
    McDaniel KD
    Clin Pediatr (Phila); 1986 Feb; 25(2):65-71. PubMed ID: 2417773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of attention-deficit-hyperactivity disorder.
    Elia J; Ambrosini PJ; Rapoport JL
    N Engl J Med; 1999 Mar; 340(10):780-8. PubMed ID: 10072414
    [No Abstract]   [Full Text] [Related]  

  • 17. World wide use of psychotropic drugs in child and adolescent psychiatric disorders.
    Simeon JG; Wiggins DM; Williams E
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 May; 19(3):455-65. PubMed ID: 7624496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicating children with attention deficit disorder.
    Wiener JM
    Pediatrics; 1988 Nov; 82(5):812. PubMed ID: 3186370
    [No Abstract]   [Full Text] [Related]  

  • 19. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
    Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730
    [No Abstract]   [Full Text] [Related]  

  • 20. Methylphenidate in hyperactive boys with comorbid tic disorder: II. Short-term behavioral effects in school settings.
    Gadow KD; Nolan EE; Sverd J
    J Am Acad Child Adolesc Psychiatry; 1992 May; 31(3):462-71. PubMed ID: 1592778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.